Epibatidine induces long-term potentiation (LTP) via activation of α4β2 nicotinic acetylcholine receptors (nAChRs) in vivo in the intact mouse dentate gyrus: Both α7 and α4β2 nAChRs essential to nicotinic LTP

Journal of Pharmacological Sciences

Volumn 93, Issue 2, 2003, Pages 180-187

  Matsuyama, Shogo ^a   Matsumoto, Akira ^b  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

Author keywords

Choline; Epibatidine; Long term potentiation (in vivo); Nicotine; Nicotinic acetylcholine receptor

Indexed keywords

ALPHA4BETA2 NICOTINIC ACETYLCHOLINE RECEPTOR; ALPHA4BETA2 NICOTINIC ACETYLCHOLINE RECEPTOR STIMULATING AGENT; BUNGAROTOXIN RECEPTOR; CHOLINE; EPIBATIDINE; MECAMYLAMINE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; DEPRESSION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG POTENCY; DRUG POTENTIATION; IN VIVO STUDY; LONG TERM POTENTIATION; MOUSE; NERVE CELL PLASTICITY; NONHUMAN;

ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; CHOLINE; DENTATE GYRUS; DRUG SYNERGISM; LONG-TERM POTENTIATION; MECAMYLAMINE; MICE; MICE, INBRED C57BL; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PYRIDINES; RECEPTORS, NICOTINIC;

EID: 0242720568     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.93.180     Document Type: Article

References (40)

1. Gotti C, Fornasari D, Clementi F. Human neuronal nicotinic receptors. Prog Neurobiol. 1997;53:199-237.
2. Levin ED. Nicotinic systems and cognitive function. Psychopharmacology (Berl). 1992;108:417-431.
3. Bliss TVP, Lomo T. Long-term potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of perforant path. J Physiol. 1973;232:331-356.
4. Bliss TVP, Collingridge GL. A synaptic model of memory: Long-term potentiation in the hippocampus. Nature. 1993;361:31-39.
5. Doyere V, Laroche S. Linear relationship between the maintenance of hippocampal long-term potentiation and retention of an associative memory. Hippocampus. 1992;2:39-48.
6. Fujii S, Ji Z, Morita N, Sumikawa K. Acute and chronic nicotine exposure differentially facilitate the induction of LTP. Brain Res. 1999;846:137-143.
7. Matsuyama S, Matsumoto A, Enomoto T, Nishizaki T. Activation of nicotinic acetylcholine receptors induces long-term potentiation in vivo in the intact mouse dentate gyrus. Eur J Neurosci. 2000;12:3741-3747.
8. Alkondon M, Albuquerque EX. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes. J Pharmacol Exp Ther. 1993;265:1455-1473.
9. Role LW, Berg DK. Nicotinic receptors in the development and modulation of CNS synapses. Neuron. 1996;16:1077-1085.
10. Arendash GW, Sengstock GJ, Sanberg PR, Kem WR. Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21. Brain Res. 1995;674:252-259.
11. Buccafusco JJ, Jackson WJ, Terry AV, Marsh KC, Decker MW, Americ SP. Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: A novel cholinergic channel activator for memory enhancement. Psychopharmacology (Berl). 1995;120:256-266.
12. Bancroft A, Levin ED. Ventral hippocampal α4β2 nicotinic receptors and chronic nicotine effects on memory. Neuropharmacology. 2000;39:2770-2778.
13. Felix R, Levin ED. Nicotinic antagonist administration into the ventral hippocampus and spatial working memory in rats. Neuroscience. 1997;81:1009-1017.
14. Alkondon M, Pereira EFR, Albuquerque EX. α-Bungarotoxin- and methyllycaconitine-sensitive nicotinic receptors mediate fast synaptic transmission in interneurons of rat hippocampal slices. Brain Res. 1998;810:257-263.
15. Alkondon M, Pereira EFR, Eisenberg HM, Albuquerque EX. Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices. J Neurosci. 1999;19:2693-2705.
16. Alkondon M, Pereira EFR, Barbosa CTF, Albuquerque EX. Neuronal nicotinic acetylcholine receptor activation modulates γ-aminobutyric acid release from CA1 neurons of rat hippocampal slices. J Pharmacol Exp Ther. 1997;283:1396-1411.
17. Frazier CJ, Buhler AV, Weiner JL, Dunwiddie TV. Synaptic potentials mediated via α-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal interneurons. J Neurosci. 1998;18:8228-8235.
18. Gray R, Rajan AS, Radcliffe KA, Yakehiro M, Dani JA. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature. 1996;383:713-716.
19. Alkondon M, Pereira EFR, Almedia LEF, Randall, WRR, Albuquerque EX. Nicotine at concentrations found in cigarette smokers activates and desensitizes nicotinic acetylcholine receptors in CA1 interneurons of rat hippocampus. Neuropharmacology. 2000;39:2726-2739.
20. Lu Y, Grady S, Marks MJ, Picciotto M, Changeux J-P, Collins AC. Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes. J Pharmacol Exp Ther. 1998;287:648-657.
21. Hunter BE, De Fiebre CM, Papke R, Kem WR, Meyer EM. A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus. Neurosci Lett. 1994;168:130-134.
22. Mansvelder HD, McGehee DS. Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron. 2000;27:349-357.
23. Spande TF, Garraffo HM, Edwards MW, Yeh HJC, Pannell L, Daly JW. Epibatidine: A novel (chloropyridyl)azabicycloheptane with potent analgesic activity from an Ecuadoran poison frog. J Am Chem Soc. 1992;114:3475-3478.
24. Alexander S, Mathie A, Peters J. Tips nomenclature supplement 2001. Trends Pharmacol Sci. 2001;1-146.
25. Alkondon M, Albuquerque E.X. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. III. Agonist actions of the novel alkaloid epibatidine and analysis of type II current. J Pharmacol Exp Ther. 1995;274:771-782.
26. Badio B, Daly JW. Epibatidine, a potent analgetic and nicotinic agonist. Mol Pharmacol. 1994;45:563-569.
27. Bonhaus DW, Bley KR, Broka CA, et al. Characterization of the electrophysiological, biochemical and behavioral actions of epibatidine. J Pharmacol Exp Ther. 1995;272:1199-1203.
28. Sullivan JP, Decker MW, Brioni JD, et al. (±)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors. J Pharmacol Exp Ther. 1994;271:624-631.
29. Marubio LM, Arroyo-Jimenez M del M, Cordero-Erausquin M, et al. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature. 1999;398:805-810.
30. Marks MJ, Smith KW, Collins AC. Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain. J Pharmacol Exp Ther. 1998;287:648-657.
31. Namgung U, Valcourt E, Routtenberg A. Long-term potentiation in vivo in the intact mouse hippocampus. Brain Res. 1995;689:85-92.
32. Cordero-Erausquin M, Marubio LM, Klink R, Changeux J-P. Nicotinic receptor function: New perspectives from knockout mice. Trends Pharmacol Sci. 2000;21:211-217.
33. Jones S, Sudweeks S, Yakel JL. Nicotinic receptors in the brain: Correlating physiology with function. Trends Neurosci. 1999;22:555-561.
34. Fisher M, Huangfu D, Shen TY, Guyenet PG. Epibatidine, analkaloid from the poison frog Epipedobates tricolor, is a powerful ganglionic depolarizing agent. J Pharmacol Exp Ther. 1994;270:702-707.
35. Buisson B, Vallejo YF, Green WN, Bertrand D. The unusual nature of epibatidine responses at the α4β2 nicotinic acetylcholine receptor. Neuropharmacology. 2000;39:2561-2569.
36. Gerzanich V, Peng X, Wang F, et al. Comparative pharmacology of epibatidine: A potent agonist for neuronal nicotine acetylcholine receptors. Mol Pharmacol. 1995;48:774-782.
37. O'Dell TJ, Christensen BN. Mecamylamine is a selective non-competitive antagonist of N-methyl-D-aspartate- and aspartate-induced currents in horizontal cells dissociated from the catfish retina. Neurosci Lett. 1988;94:93-98.
38. Elrod K, Buccafusco JJ. Correlation of the amnestic effects of nicotinic antagonists with inhibition of regional brain acetylcholine synthesis in rats. J Pharmacol Exp Ther. 1991;258:403-409.
39. Dilts SL, Berry CA. Effect of cholinergic drugs on passive avoidance in the mouse. J Pharmacol Exp Ther. 1967;158:279-285.
40. Woodruff-Pak DS, Hichliffe RM. Mecamylamine- or scopolamine-induced learning impairment: Ameliorated by nefiracetam. Psychopharmacology (Berl). 1997;131:130-139.